Resultados da pesquisa - John Joseph Borg

Alzheimer's disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy? Por Daniela Melchiorri, Sara Merlo, Benjamin Micallef, John-Joseph Borg, John-Joseph Borg, František Dráfi, František Dráfi

Connect to this object online.

Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective Por Martin Šíma, Andrea Laslop, John Joseph Borg, John Joseph Borg, Silvester Poništ, Daniela Melchiorri, František Dráfi, František Dráfi

Connect to this object online.

Changing paradigms in bioequivalence trials submitted to the EMA for evaluation - A clinical and regulatory perspective Por Nathaniel Refalo, Daniel Chetcuti, Amy Tanti, Anthony Serracino-Inglott, John Joseph Borg

Connect to this object online.

Where is Industry Getting it Wrong? A Review of Quality Concerns Raised at Day 120 by the Committee for Medicinal Products for Human Use during European Centralised Marketing Autho... Por John Joseph Borg, Jean-Louis Robert, George Wade, George Aislaitner, Michal Pirozynski, Eric Abadie, Tomas Salmonson, Patricia Vella Bonanno

Connect to this object online.